Agree with Metatag, at sub 3 cents you are buying the move undervalued tech play on the ASX. And we are not even pricing IBN here. They sold 68 properties in 1Q vs 101 in FY15. On track for TRIPLE digit growth DYOR NOT ADVICE
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game